Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons

[1]  Jeffrey D Dawson,et al.  Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. , 2007, The American journal of psychiatry.

[2]  T. Kosten,et al.  Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia , 2007, Schizophrenia Research.

[3]  T. Shinkai,et al.  No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case–control study and meta-analysis , 2007, Neuroscience Letters.

[4]  H. Yamasue,et al.  No evidence for an association between the BDNF Val66Met polymorphism and schizophrenia or personality traits , 2006, Schizophrenia Research.

[5]  Arnoldo Frigessi,et al.  BDNF gene variants and brain morphology in schizophrenia , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  T. Wassink,et al.  Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. , 2006, Archives of general psychiatry.

[7]  S. Cichon,et al.  Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: An association study , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  Y. Kaneda,et al.  Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms , 2006, Neuroscience Letters.

[9]  Margit Burmeister,et al.  BDNF Val66Met Allele Is Associated with Reduced Hippocampal Volume in Healthy Subjects , 2006, Biological Psychiatry.

[10]  Takashi Asada,et al.  The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology , 2006, Neuroscience Letters.

[11]  Yasuhiro Kawasaki,et al.  Morphologic alterations of the parcellated superior temporal gyrus in schizophrenia spectrum , 2006, Schizophrenia Research.

[12]  Peter Falkai,et al.  Effects of antipsychotics on brain structure , 2006, Current opinion in psychiatry.

[13]  Y. Kawasaki,et al.  Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis. , 2005, Brain : a journal of neurology.

[14]  D Robinson,et al.  Brain-derived neurotrophic factor Val66met polymorphism and volume of the hippocampal formation , 2005, Molecular Psychiatry.

[15]  A. Sampson,et al.  Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia , 2005, The Journal of Neuroscience.

[16]  Y. Kawasaki,et al.  Volume reduction of the amygdala in patients with schizophrenia: a magnetic resonance imaging study , 2004, Psychiatry Research: Neuroimaging.

[17]  A. Meyer-Lindenberg,et al.  The Brain-Derived Neurotrophic Factor val66met Polymorphism and Variation in Human Cortical Morphology , 2004, The Journal of Neuroscience.

[18]  Kenji Hashimoto,et al.  Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[19]  S. Tsai,et al.  Association Study of a Brain-Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism and Personality Trait and Intelligence in Healthy Young Females , 2004, Neuropsychobiology.

[20]  S. Tsai,et al.  An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients , 2003, Neuroscience Letters.

[21]  Yasuhiro Kawasaki,et al.  Decreased volume and increased asymmetry of the anterior limb of the internal capsule in patients with schizophrenia , 2003, Biological Psychiatry.

[22]  M. Egan,et al.  Brain-Derived Neurotrophic Factor val66met Polymorphism Affects Human Memory-Related Hippocampal Activity and Predicts Memory Performance , 2003, The Journal of Neuroscience.

[23]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[24]  Bai Lu,et al.  BDNF and activity-dependent synaptic modulation. , 2003, Learning & memory.

[25]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[26]  J. Kleinman,et al.  BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. , 2002, Brain research. Developmental brain research.

[27]  P. Goldman-Rakic,et al.  Smaller frontal gray matter volume in postmortem schizophrenic brains. , 2002, The American journal of psychiatry.

[28]  Y. Kawasaki,et al.  Lack of normal structural asymmetry of the anterior cingulate gyrus in female patients with schizophrenia: a volumetric magnetic resonance imaging study , 2002, Schizophrenia Research.

[29]  R. McCarley,et al.  A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.

[30]  T. Schormann,et al.  Hemispheric Shape of European and Japanese Brains: 3-D MRI Analysis of Intersubject Variability, Ethnical, and Gender Differences , 2001, NeuroImage.

[31]  P. Sokoloff,et al.  Brain Derived Neurotrophic Factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia , 2000, Molecular Psychiatry.

[32]  B. Lu,et al.  Neurotrophins and hippocampal synaptic transmission and plasticity , 1999, Journal of neuroscience research.

[33]  Karl J. Friston,et al.  The left medial temporal region and schizophrenia. A PET study. , 1992, Brain : a journal of neurology.

[34]  G. Roberts Schizophrenia: A Neuropathological Perspective , 1991, British Journal of Psychiatry.

[35]  O. Guillin,et al.  Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine. , 2007, International review of neurobiology.

[36]  Dennis Velakoulis,et al.  Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. , 2005, Schizophrenia bulletin.

[37]  N. Makris,et al.  A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. , 2003, Schizophrenia bulletin.

[38]  J. Kleinman,et al.  Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia , 2003, Molecular Psychiatry.

[39]  Mu-ming Poo,et al.  Neurotrophins as synaptic modulators , 2001, Nature Reviews Neuroscience.

[40]  P. Goldman-Rakic,et al.  Functional and anatomical aspects of prefrontal pathology in schizophrenia. , 1997, Schizophrenia bulletin.